Alicia Gonzalez-Martinez, Ancor Sanz-García, David García-Azorín, Jaime Samuel Rodriguez-Vico, Alex Jaimes, Andrea Gómez García, Javier Casas Limón, Javier Díaz de Terán, María Sastre-Real, Javier Membrilla, Germán Latorre, Carlos Calle de Miguel, Sendoa Gil Luque, Cristina Trevino-Peinado, Sonia Quintas, Patricia Heredia, Ana Echavarría Íñiguez, Ángel Guerrero-Peral, Álvaro Sierra, Nuria González-García, Jesús Porta-Etessam, Ana Beatriz Gago-Veiga
OBJECTIVE: To evaluate clinical characteristics, effectiveness, and tolerability of preventive anti-CGRP mAbs in the elderly. Anti-CGRP mAbs have demonstrated efficacy and safety in patients with migraine although there is limited information regarding the elderly. DESIGN: We performed a multicenter case-control study of cases(patients over 65 years old) and controls(sex-matched patients under 55 years old) with migraine receiving anti-CGRP mAbs. METHODS: We included the demographic characteristics, effectiveness-reduction in the number of monthly headache days(MHD) and monthly migraine days(MMD),30%,50% and 75% responder rates- and treatment emergent adverse events(TEAEs);the primary endpoint was the 50% response rate regarding MHD at weeks 20-24; exploratory 50% response predictors in the elderly were evaluated...
October 17, 2023: Pain Medicine